The Haemostasis Registry Team
• Project Leaders
- Peter Cameron
- Louise Phillips
• Project Officer
- Amanda Zatta
• Administration
- Rosalie Clementson
- Alice Noone
- Nikita Schembri
• Database Management
- M Pruksawongsin
• Clerical Assistance
- Julian Murphy
- Jim Cameron
- Dianne Waters
• Publications
- Dev Mitra
- Cameron Willis
• Statistical Advice
- Damien Jolley
• Data Collection Team
The Haemostasis Registry Team
Steering Committee
- Prof James Isbister (Chair)
- Prof Peter Cameron
- Prof John McNeil
- Dr Louise Phillips
- Dr Scott Dunkley
- Prof Hatem Salem
- Ms Wendy Thomas
Big Thank You To…..
Local Investigators
and
Data Collectors
at participating hospitals
Novo Nordisk Pharmaceuticals Pty Ltd
Haemostasis Registry Publications
Published Manuscripts
• Cameron PA, Phillips L, Balogh Z, Jankelowitz G, Joseph A, Parr M, Pearce A,
Recombinant Activated Factor VII in trauma: experience from the Australian
and New Zealand Haemostasis Register. Injury 2007 38(9):1030-8.
• Isbister J, Dunkley S, Cameron P, Phillips L. The Australasian haemostasis
register for clinical use of recombinant activated factor VII. IsBT Science
Series 2007;2: 110-112
• Isbister J, Phillips L, Dunkley S, Jankelowitz G, McNeil J and Cameron P.
Recombinant activated factor VII in critical bleeding: experience from the
Australian and New Zealand Haemostasis Register. Internal Medicine Journal
2008; 38(3): 156–165
• Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G,
Cameron P. Recombinant Activated Factor VII in cardiac surgery: experience
from the Australian and New Zealand Haemostasis Register. Annals of
Thoracic Surgery 2008; 85:836-844
Haemostasis Registry Publications
Submitted Manuscripts
• Phillips L, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R,
Cameron P. Recombinant Activated Factor VII in obstetric haemorrhage:
experiences from the Australian and New Zealand Haemostasis Register.
Anesthesia and Analgesia
• Willis, CD, Cameron PA, Phillips LE. Variation in the use of Recombinant
Activated Factor VII in critical bleeding. Internal Medicine Journal
• Mitra B, Phillips LE, Cameron PA, Billah B, Reid C. Safety surveillance of the
use of Recombinant Factor VII in Cardiac Surgery. Anaesthesia and Intensive
Care
• Phillips LE, Zatta AJ, Schembri NL, Noone AK, Isbister J. Uncontrolled
Bleeding in Surgical Patients: the role of recombinant activated factor VIIa.
Current Drug Targets
• Willis CD, Bird R, Mullany D, Cameron PA, Phillips LE. Use of rFVIIa for critical
bleeding in Cardiac Surgery: dose variation and patient outcomes. Transfusion
Haemostasis Registry Publications
Manuscripts in Preparation
• Flower, O. Cameron PA, Gunn K, Dunkley S, Watts A, Rajbhandari D, Phillips
LE. Recombinant Activated Factor VII in Liver Patients: experiences from the
Australian and New Zealand Haemostasis Register. (in prep)
• Polizzotto MN, Phillips LE, Cole-Sinclair M, Dunkley S, Wood E, Cameron PA.
Recombinant activated Factor VII for bleeding in the setting of malignancy and
hematopoietic stem cell transplantation. (in prep)
• Willis CD, Phillips LE, Dunkley S, Isbister J, Cameron PA. Adherence to
transfusion protocols and the use of recombinant activated Factor VII. (in prep)
• Willis CD, Phillips LE, Cameron PA. Giving rFVIIa in the seemingly hopeless
setting of AAA. (in prep)
• McQuilten Z, Phillips LE. Big bleeds in little people: recombinant Factor VIIa
use in paediatrics. (in prep)
• Mitra B, Phillips LE, Zatta A, Cameron PA. Entering the “triad of death” and the
concept of futility in the use of recombinant activated factor VII. (in prep)
For 2009.....
• Re-visit audit
• Effect of anticoagulant and antiplatelet medications
• Acquired haemophilia
• Jehovah’s witness patients
• Cost-effectiveness study
Your ideas and interest in these and other topics is
welcomed